MMP9 and neoplasm: In addition to their immunosuppressive ability, MDSCs could contribute to tumor angiogenesis primarily via the secretion of MMP9, which increased the bioavailability of VEGF, thereby destroying angiogenic dormancy and facilitating tumor metastasis (68, 69).